Skip to content

Hepatitis E Infection : Emergence Mechanisms in North-Eastern France of Polymorphic Clinical Forms.

Hepatitis E Infection : Emergence Mechanisms in North-Eastern France of Polymorphic Clinical Forms.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03524014
Acronym
VHENE
Enrollment
40
Registered
2018-05-14
Start date
2018-05-15
Completion date
2020-12-30
Last updated
2018-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatitis E Infection in Humans and in Environment

Brief summary

The present research aims to collect virological and clinical data on hepatitis E virus (HEV) infections, either in acute or chronic forms of HEV infection in North-Eastern France, with liver- or non liver-related symptoms, plus data on HEV circulation in the outside environment. The purpose of this study is to improve the diagnosis and care of HEV-infected patients, as well as the preventive features to take into account in order to avoid food- and environment-borne infections. At last, we will investigate HEV molecular characteristics, with the hypothesis that some advantageous HEV strains coul be more pathogenic for some tissues and/or organs.

Interventions

OTHEROnly advice for diagnosis and prevention

Only advice for diagnosis and prevention

Sponsors

Central Hospital, Nancy, France
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* HEV-infected patients, with hepatitis and/or neurological and/or renal symptoms

Exclusion criteria

* Patients, with hepatitis and/or neurological and/or renal symptoms, infected by other viruses leading to hepatitis (hepatitis B, hepatitis C, hepatitis A ...)

Design outcomes

Primary

MeasureTime frameDescription
Anti-HEV IgM (qualitative assay);2 yearsGuidelines to improve HEV detection by using the 2 virological assays
HEV RNA (quantitative PCR assay)2 yearsGuidelines to improve HEV detection by using the 2 virological assays

Countries

France

Contacts

Primary ContactEvelyne SCHVOERER, Pr
e.schvoerer@chru-nancy.fr0383155269

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026